(Q38050504)

27 August 2017

siRNA and cancer immunotherapy (English)

1 reference

27 August 2017

1 reference

Soudeh Ghafouri-Fard

1

1 reference

PubMed ID

23046235

27 August 2017

Somayyeh Ghafouri-Fard

series ordinal

2

1 reference

PubMed ID

23046235

27 August 2017

language of work or name

1 reference

1 September 2012

1 reference

27 August 2017

1 reference

27 August 2017

4

1 reference

27 August 2017

9

1 reference

27 August 2017

907-917

1 reference

Immunotherapy in nonmelanoma skin cancer

27 August 2017

1 reference

Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance

21 January 2018

1 reference

Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells

21 January 2018

1 reference

Immunotherapeutic strategies employing RNA interference technology for the control of cancers

21 January 2018

1 reference

Introduction of a Chimeric Chalcone Synthase Gene into Petunia Results in Reversible Co-Suppression of Homologous Genes in trans

21 January 2018

1 reference

Quelling: transient inactivation of gene expression in Neurospora crassa by transformation with homologous sequences

21 January 2018

1 reference

Current progress of siRNA/shRNA therapeutics in clinical trials

21 January 2018

1 reference

siRNA-based approaches in cancer therapy

21 January 2018

1 reference

siRNA and isRNA: two edges of one sword

21 January 2018

1 reference

siRNA and innate immunity

21 January 2018

1 reference

Impact of delivery systems on siRNA immune activation and RNA interference

21 January 2018

1 reference

siRNA-induced immunostimulation through TLR7 promotes antitumoral activity against HPV-driven tumors in vivo.

21 January 2018

1 reference

5'-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma

21 January 2018

1 reference

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7

21 January 2018

1 reference

Sequence determinants of innate immune activation by short interfering RNAs.

21 January 2018

1 reference

Sequence- and target-independent angiogenesis suppression by siRNA via TLR3

21 January 2018

1 reference

A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA.

21 January 2018

1 reference

Skin delivery of short hairpin RNA of indoleamine 2,3 dioxygenase induces antitumor immunity against orthotopic and metastatic liver cancer.

21 January 2018

1 reference

STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response.

21 January 2018

1 reference

Structure and function of a new STAT-induced STAT inhibitor

21 January 2018

1 reference

Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity

21 January 2018

1 reference

An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells

21 January 2018

1 reference

Inhibitory RNA molecules in immunotherapy for cancer

21 January 2018

1 reference

In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses

21 January 2018

1 reference

A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppression

21 January 2018

1 reference

DIgR2, dendritic cell-derived immunoglobulin receptor 2, is one representative of a family of IgSF inhibitory receptors and mediates negative regulation of dendritic cell-initiated antigen-specific T-cell responses

21 January 2018

1 reference

Small interfering RNA-mediated knockdown of notch ligands in primary CD4+ T cells and dendritic cells enhances cytokine production.

21 January 2018

1 reference

PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells

21 January 2018

1 reference

PD-L1 co-stimulation, ligand-induced TCR down-modulation and anti-tumor immunotherapy.

21 January 2018

1 reference

siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen-specific CD8+ T cells.

21 January 2018

1 reference

Small interference RNA modulation of IL-10 in human monocyte-derived dendritic cells enhances the Th1 response

21 January 2018

1 reference

Vaccination with dendritic cells transfected with BAK and BAX siRNA enhances antigen-specific immune responses by prolonging dendritic cell life

21 January 2018

1 reference

Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity

21 January 2018

1 reference

Enhancing siRNA effects in T cells for adoptive immunotherapy

21 January 2018

1 reference

GATA-3 in human T cell helper type 2 development

21 January 2018

1 reference

CTLA4 silencing with siRNA promotes deviation of Th1/Th2 in chronic hepatitis B patients

21 January 2018

1 reference

Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis.

21 January 2018

1 reference

Toll-like receptors on tumor cells facilitate evasion of immune surveillance

21 January 2018

1 reference

TLR signaling by tumor and immune cells: a double-edged sword

21 January 2018

1 reference

The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells

21 January 2018

1 reference

Reinstalling antitumor immunity by inhibiting tumor-derived immunosuppressive molecule IDO through RNA interference

21 January 2018

1 reference

Tumor-driven evolution of immunosuppressive networks during malignant progression

21 January 2018

1 reference

VEGF-targeted therapy: mechanisms of anti-tumour activity.

21 January 2018

1 reference

Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model.

21 January 2018

1 reference

Reversal of tumor-induced immunosuppression by TGF-beta inhibitors

21 January 2018

1 reference

Toll-like receptor 4 activation in cancer progression and therapy

21 January 2018

1 reference

Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen-specific regulatory T cells, and suppresses experimental inflammatory arthritis

21 January 2018

1 reference

Silencing of the TGF-β1 gene increases the immunogenicity of cells from human ovarian carcinoma

21 January 2018

1 reference

An injectable synthetic immune-priming center mediates efficient T-cell class switching and T-helper 1 response against B cell lymphoma.

21 January 2018

1 reference

Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy

21 January 2018

1 reference

Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications

21 January 2018

1 reference

Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines

21 January 2018

1 reference

Nanovector delivery of siRNA for cancer therapy

21 January 2018

1 reference

Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer

21 January 2018

1 reference

RNA-based therapeutics: current progress and future prospects.

21 January 2018

1 reference

Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice

21 January 2018

1 reference

Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation

21 January 2018

1 reference

Nonviral methods for siRNA delivery

21 January 2018

1 reference

RNAi-mediated gene silencing in non-human primates.

21 January 2018

1 reference

Can animal models of disease reliably inform human studies?

21 January 2018

1 reference

In vivo imaging of RNA interference

21 January 2018

1 reference

Toll-like receptor signalling

21 January 2018

1 reference

Toll-like receptor modulators: a patent review (2006-2010).

21 January 2018

1 reference

Tumor evasion from T cell surveillance

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/IMT.12.87

1 reference

27 August 2017

1 reference

PubMed ID

23046235